Cargando…
NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA
PURPOSE: The current study aims to test the hypothesis that the ratio of T1-weighted image to T2-weighted image signal intensity (T1w/T2w-Ratio: rT1/T2), an imaging surrogate developed for myelin integrity, is predictive of histologically lower-grade glioma's IDH mutation status. MATERIALS AND...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719351/ http://dx.doi.org/10.1093/noajnl/vdac167.066 |
_version_ | 1784843304962097152 |
---|---|
author | Sanada, Takahiro Yamamoto, Shota Sakai, Mio Umehara, Toru Sato, Hirotaka Saito, Masato Mitsui, Nobuyuki Hiroshima, Satoru Anei, Ryogo Kanemura, Yonehiro Tanino, Mishie Nakanishi, Katsuyuki Kishima, Haruhiko Kinoshita, Manabu |
author_facet | Sanada, Takahiro Yamamoto, Shota Sakai, Mio Umehara, Toru Sato, Hirotaka Saito, Masato Mitsui, Nobuyuki Hiroshima, Satoru Anei, Ryogo Kanemura, Yonehiro Tanino, Mishie Nakanishi, Katsuyuki Kishima, Haruhiko Kinoshita, Manabu |
author_sort | Sanada, Takahiro |
collection | PubMed |
description | PURPOSE: The current study aims to test the hypothesis that the ratio of T1-weighted image to T2-weighted image signal intensity (T1w/T2w-Ratio: rT1/T2), an imaging surrogate developed for myelin integrity, is predictive of histologically lower-grade glioma's IDH mutation status. MATERIALS AND METHODS: 25 histologically and molecularly confirmed lower-grade glioma patients with eight IDH-wildtype (IDHwt) and 17 IDH-mutant (IDHmt) tumors at Asahikawa Medical University Hospital (AMUH) were used as a test cohort. Twenty-nine patients (IDHwt: 13, IDHmt: 16) from Osaka International Cancer Institute (OICI) and 101 patients from the Cancer Imaging Archive (TCIA) / Cancer Genome Atlas (TCGA) dataset (IDHwt: 19, IDHmt: 82) were used as external cohorts. rT1/T2 images were calculated from T1- and T2-weighted images using a recommended signal correction. The relationship between the mean rT1/T2 (mrT1/T2) and the IDH mutation status was investigated. Moreover, t-Distributed Stochastic Neighbor Embedding (t-SNE) investigated the difference in MRI qualities and characteristics between the three cohorts. RESULTS: The test cohort at AMUH revealed that mrT1/T2 of IDHwt tumors was significantly higher than that of IDHmt tumors (p < 0.05) and that the optimal cut-off of mrT1/T2 for discriminating IDHmt was 0.666-0.677, (AUC = 0.75, p < 0.05), which finding was validated by the external domestic cohort at OICI (AUC = 0.75, p = 0.02). However, the external international cohort deriving from TCIA/TCGA could not validate this (AUC = 0.63, p = 0.08). t-SNE analysis revealed that the difference in image characteristics within the cohort was more diverse for the TCIA/TCGA than for the two domestic cohorts. CONCLUSION: The current study revealed that mrT1/T2 was able to discriminate IDHwt and IDHmt tumors in two domestic cohorts significantly. This was not validated by the TCIA/TCGA cohort due to the wide variety in the original imaging characteristics of the TCIA/TCGA cohort. |
format | Online Article Text |
id | pubmed-9719351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-97193512022-12-06 NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA Sanada, Takahiro Yamamoto, Shota Sakai, Mio Umehara, Toru Sato, Hirotaka Saito, Masato Mitsui, Nobuyuki Hiroshima, Satoru Anei, Ryogo Kanemura, Yonehiro Tanino, Mishie Nakanishi, Katsuyuki Kishima, Haruhiko Kinoshita, Manabu Neurooncol Adv Abstracts PURPOSE: The current study aims to test the hypothesis that the ratio of T1-weighted image to T2-weighted image signal intensity (T1w/T2w-Ratio: rT1/T2), an imaging surrogate developed for myelin integrity, is predictive of histologically lower-grade glioma's IDH mutation status. MATERIALS AND METHODS: 25 histologically and molecularly confirmed lower-grade glioma patients with eight IDH-wildtype (IDHwt) and 17 IDH-mutant (IDHmt) tumors at Asahikawa Medical University Hospital (AMUH) were used as a test cohort. Twenty-nine patients (IDHwt: 13, IDHmt: 16) from Osaka International Cancer Institute (OICI) and 101 patients from the Cancer Imaging Archive (TCIA) / Cancer Genome Atlas (TCGA) dataset (IDHwt: 19, IDHmt: 82) were used as external cohorts. rT1/T2 images were calculated from T1- and T2-weighted images using a recommended signal correction. The relationship between the mean rT1/T2 (mrT1/T2) and the IDH mutation status was investigated. Moreover, t-Distributed Stochastic Neighbor Embedding (t-SNE) investigated the difference in MRI qualities and characteristics between the three cohorts. RESULTS: The test cohort at AMUH revealed that mrT1/T2 of IDHwt tumors was significantly higher than that of IDHmt tumors (p < 0.05) and that the optimal cut-off of mrT1/T2 for discriminating IDHmt was 0.666-0.677, (AUC = 0.75, p < 0.05), which finding was validated by the external domestic cohort at OICI (AUC = 0.75, p = 0.02). However, the external international cohort deriving from TCIA/TCGA could not validate this (AUC = 0.63, p = 0.08). t-SNE analysis revealed that the difference in image characteristics within the cohort was more diverse for the TCIA/TCGA than for the two domestic cohorts. CONCLUSION: The current study revealed that mrT1/T2 was able to discriminate IDHwt and IDHmt tumors in two domestic cohorts significantly. This was not validated by the TCIA/TCGA cohort due to the wide variety in the original imaging characteristics of the TCIA/TCGA cohort. Oxford University Press 2022-12-03 /pmc/articles/PMC9719351/ http://dx.doi.org/10.1093/noajnl/vdac167.066 Text en © The Author(s) 2022. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstracts Sanada, Takahiro Yamamoto, Shota Sakai, Mio Umehara, Toru Sato, Hirotaka Saito, Masato Mitsui, Nobuyuki Hiroshima, Satoru Anei, Ryogo Kanemura, Yonehiro Tanino, Mishie Nakanishi, Katsuyuki Kishima, Haruhiko Kinoshita, Manabu NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA |
title | NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA |
title_full | NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA |
title_fullStr | NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA |
title_full_unstemmed | NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA |
title_short | NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA |
title_sort | ni-13 the ratio of t1-weighted to t2-weighted signal intensity and idh mutation in glioma |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719351/ http://dx.doi.org/10.1093/noajnl/vdac167.066 |
work_keys_str_mv | AT sanadatakahiro ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT yamamotoshota ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT sakaimio ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT umeharatoru ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT satohirotaka ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT saitomasato ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT mitsuinobuyuki ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT hiroshimasatoru ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT aneiryogo ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT kanemurayonehiro ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT taninomishie ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT nakanishikatsuyuki ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT kishimaharuhiko ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma AT kinoshitamanabu ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma |